Related Experiment Video
Updated: Mar 30, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Molding BRCA2 function through its interacting partners
Juan S Martinez1,2, Céline Baldeyron1,2, Aura Carreira1,2
1a Institut Curie; Centre de Recherche ; Orsay , France.
Abstract:
The role of the tumor suppressor BRCA2 has been shaped over 2 decades thanks to the discovery of its protein and nucleic acid partners, biochemical and structural studies of the protein, and the functional evaluation of germline variants identified in breast cancer patients. Yet, the pathogenic and functional effect of many germline mutations in BRCA2 remains undetermined, and the heterogeneity of BRCA2-associated tumors challenges the identification of causative variants that drive tumorigenesis. In this review, we propose an overview of the established and emerging interacting partners and functional pathways attributed to BRCA2, and we speculate on how variants altering these functions may contribute to cancer susceptibility.
Insights
The tumor suppressor BRCA2
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The tumor suppressor BRCA2 is crucial in DNA repair and maintaining genomic stability.
- Over two decades of research have elucidated BRCA2's partners and functions, particularly in breast cancer.
- However, the impact of many BRCA2 germline mutations remains unclear, complicating cancer susceptibility analysis.
Purpose of the Study:
- To review established and emerging BRCA2 interacting partners and functional pathways.
- To explore how variants in BRCA2 contribute to cancer susceptibility.
- To address the challenge of identifying causative variants in heterogeneous BRCA2-associated tumors.
Main Methods:
- Literature review of biochemical and structural studies.
- Analysis of functional evaluations of germline variants in breast cancer patients.
- Synthesis of data on BRCA2 interacting partners and pathways.
Main Results:
- BRCA2's role in DNA repair is well-established through its partners and functions.
- Numerous germline mutations in BRCA2 have undetermined pathogenic and functional effects.
- Tumor heterogeneity in BRCA2-associated cancers complicates variant identification.
Conclusions:
- Understanding BRCA2's interactome and pathways is key to deciphering its role in cancer.
- Variants affecting BRCA2 functions likely contribute to cancer susceptibility.
- Further research is needed to clarify the impact of undetermined BRCA2 mutations.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Restarting Stalled Replication Forks
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
DNA Damage can Stall the Cell Cycle

